SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-22-006857
Filing Date
2022-03-21
Accepted
2022-03-21 19:27:04
Documents
1
Period of Report
2022-02-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1332
  Complete submission text file 0001437749-22-006857.txt   2861
Mailing Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526
Business Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526 (888) 613-8802
Statera Biopharma, Inc. (Issuer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 167 CARMELA COURT JUPITER FL 33478
Business Address
Chandrasekhar Satishchandran (Reporting) CIK: 0001832285 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32954 | Film No.: 22756851